Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 DOVU DOVU +48.35%
#3 Akedo Akedo +46.30%
#4 Velvet Velvet +35.55%
#5 Black Phoenix Black Phoenix +34.64%
#6 DoubleZero DoubleZero +19.36%
#7 Cross Cross +19.08%
#8 Cap Cap +15.07%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.43%
#10 Fake World Assets Fake World Assets +10.11%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Rang in Aktien #39567
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Aktienkurs
$0.003084
Marktkapitalisierung
$434.03K
Veränderung (1 Tag)
-7.14%
Veränderung (1 Jahr)
-89.24%
Land
BE
Handel Oxurion N.V. (OXUR)

Kategorie

Healthcare
EPS für Oxurion N.V. (OXUR)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Oxurion N.V. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Oxurion N.V. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE